| Prev Close | 124.97 |
| Open | 125.08 |
| Day Low/High | 123.68 / 126.26 |
| 52 Wk Low/High | 73.02 / 131.81 |
| Volume | 839.47K |
Quest Diagnostics Incorporated (DGX)
125.99
1.02
0.82
NYSE
| Exchange | NYSE |
| Shares Outstanding | 134.77B |
| Market Cap | 16.77B |
| P/E Ratio | 15.35 |
| Div & Yield | N.A. (N.A) |
Latest News
Sector Haves/Have Nots, Lisa Su Does It Again, Trading Tesla and Microsoft
Earnings reports continue to outperform, but can this support equity markets at these levels now?
Use DRIPs to Build a Socially Responsible Portfolio
Many quality companies that fit into the socially responsible investing camp offer direct-purchase plans, allowing investors an easy way to build an SRI portfolio.
Mid-Caps Outperform, Funding 'Paycheck Protection', U.K. Vaccine Trials
Trading volumes dropping on major indexes, U.K. teams begin human trials on a Covid-19 vaccine, and the U.S. Senate wants another stimulus package addition.
Healthy Upside Potential In Medical Devices and Services Stocks
Some of the best opportunities are in lesser-known niche markets such as medical devices and services.
Earnings Volcano Erupts, Locking In on Lam, and Apple-Intel Intel: Market Recon
Also, defense industry names can breathe easier with word of debt ceiling and federal spending deal.
3 Ways to Play Facebook Ahead of Wednesday's Earnings
Here are some options strategies for this FANG name into tomorrow's report.
Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back
The crash of oil will only accelerate the move.
Starbucks Leaves a Bitter Taste and Doesn't Suit My Investment Palate Either
For my portfolio, you can't beat this SBUX competitor -- and for a cup of coffee.
The Really Big Money Rushes to Super Bowl
This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.
Cramer: There Are Powerful Themes in Several Bull Markets
It's a wonder to me how split this market really is.
Stanley Black & Decker, Quest Diagnostics and 2 More Could Rocket Higher This Spring -- Here's Why
These four stocks are showing short-term gain catalysts and longer-term growth potential.
Quest Diagnostics Investigates Third-Party Data Breach
Shares of Quest Diagnostics were slightly higher Tuesday after announcing an investigation into a data breach by a third-party that affected the health records of 34,000 people.
Exxon Mobil CEO is Trump's Choice for Secretary of State
The 64 year old Tillerson became CEO of the Texas based oil giant in 2004 and has a close business relationship with Russian President Vladimir Putin.
Quest Diagnostics CEO on Donald Trump's Plan to Overhaul Obamacare
Quest Diagnostics CEO Stephen Rusckowski discusses the Affordable Care Act and what's next for his company.
Bullish and Bearish Reversals for the Week
Here's a window into what institutional investors may be doing and how to profit from that.
Cramer: These Stocks Are the Key to the Bull Market
Let me give you the unassailable themes.
Laboratory Corp. of America Looks Pretty Healthy
LH's $5.7B Covance takeover could be just what the doctor ordered.
Quest Diagnostics Is on a Mission to Rally
Charts show DGX should break out above resistance soon.
Theranos Must Refute Claims Specifically
Questions will continue to swirl until facts emerge.
Quest Diagnostics Can't Stop the Bleeding; 10% Slide in Sight
Quest could be vulnerable to a deep correction, but a decline to next support around $60 seems like the path of least resistance.
Jim Cramer Says Blackberry Needs a Catalyst, TransUnion Will Be a Buy
Jim Cramer answers viewers’ Twitter (TWTR) questions from the floor of the New York Stock Exchange.
